Abstract: An inkjet ink comprises phosphoric acid; one or more solvents for the phosphoric acid, preferably ethyl lactate and water; and one or more aprotic organic sulfoxides, preferably dimethyl sulfoxide (DMSO) or dimethyl sulfone (SMSO2). The inks do not leave a carbon residue on heating and so are suited to use in etching and/or doping silicon wafers, e.g. in the production of crystalline silicon solar cells.

Abstract: The present invention may include performing a first measurement on a wafer of a first lot of wafers via an omniscient sampling process, calculating a first set of process tool correctables utilizing one or more results of the measurement performed via an omniscient sampling process, randomly selecting a set of field sampling locations of the wafer of a first lot of wafers, calculating a second set of process tool correctables by applying an interpolation process to the randomly selected set of field sampling locations, wherein the interpolation process utilizes values from the first set of process tool correctables for the randomly selected set of field sampling locations in order to calculate correctables for fields of the wafer of the first lot not included in the set of randomly selected fields, and determining a sub-sampling scheme by comparing the first set of process tool correctables to the second set of correctables.

Abstract: This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders.

Abstract: This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders.

Abstract: Treatment targets such as tumors or lesions, located within an anatomical region that undergoes motion (which may be periodic with cycle P), are dynamically tracked. A 4D mathematical model is established for the non-rigid motion and deformation of the anatomical region, from a set of CT or other 3D images. The 4D mathematical model relates the 3D locations of part(s) of the anatomical region with the targets being tracked, as a function of the position in time within P. Using fiducial-less non-rigid image registration between pre-operative DRRs and intra-operative x-ray images, the absolute position of the target and/or other part(s) of the anatomical region is determined. The cycle P is determined using motion sensors such as surface markers. The radiation beams are delivered using: 1) the results of non-rigid image registration; 2) the 4D model; and 3) the position in time within P.

Abstract: A combined metrology mark, a system, and a method for calculating alignment on a semiconductor circuit are disclosed. The combined metrology mark may include a mask misregistration structure and a wafer overlay mark structure.

Abstract: The present invention relates to methods for synthesizing conformationally constrained peptides and cyclic peptidomimetics obtainable by these methods which are conformationally constrained due an internal cross-link. This cross-link is formed between the side chain of an amino acid residue or analog and a (2S, 4S)4-functionalized proline residue. The invention further relates to the use of (2S, 4S)-4-functionalized proline residues as building units in the synthesis of such peptidomimetics and to the use thereof as antigens, alone or in combination with suitable immunopotentiating delivery systems, for example immunopotentiating reconstituted influenza virosomes to elicit an immune response in a mammal. Moreover, the invention also relates to pharmaceutical compositions containing the same.

Abstract: A time indicator device comprised of first and second interconnected reservoirs containing first and second liquids respectively. A first barrier is provided between said first and second liquids to prevent said liquids mixing. Said first barrier is connected via a conduit to a third reservoir containing a third liquid which is adapted to pass along said conduit over a first predetermined time period and to effect removal of said first barrier upon contact to facilitate mixing of said first and second liquid and generation of a liquid mixture within the second reservoir of different colour to the second liquid prior to mixing and thereby provide an indication of when said first predetermined time period has elapsed.

Abstract: Compounds of Formula (I) wherein R1, R2, R3, R4, R5, R6, and R7 are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.

Abstract: The film sealing and wrapping machine with a rotary cut and seal jaw is provided. The rotary cut and seal jaw has an internal sliding mechanism which provides for smooth and quiet operation. The rotational speed of the jaw may be varied to increase through put and to provide for a title bag around products. The rotary cut and seal jaw may comprise a seal bar and pressure pad may both be spring loaded to self align the seal bar and pressure pad during the sealing and cutting process. Lastly, a gap defined by a belt disposed upstream and downstream of the seal bar and pressure pad may be mechanically linked to the pressure pad through a control carriage.

Abstract: A vending machine includes first and second integrated dispensing systems mounted at front portions of adjacent product shelf dividers establishing at least first, second and third product queues. Each of the first and second dispensing systems includes first and second release mechanisms having a plurality of hinged plates supported by a frame. The plurality of hinged plates are selectively shifted into and out of corresponding ones of the first, second and third product queues, such that each product queue has associated therewith two opposing release mechanisms. Preferably, at least one of the first and second release mechanisms for each dispensing system includes a queue spacing member which is mounted to one of the hinged plates and projects into the product queue to establish a desired spacing between the release mechanisms.

Abstract: A system to remove most or substantially all of the residual ink from an ink chamber prior to post print washing, said ink chamber comprising an ink chamber profile provided with a space for ink, at least one inlet and at least one outlet, and with upper and lower doctor blade members detachably mounted on the ink chamber profile, said blades bounding an opening which, in operation, faces and engages with the outer circumference of an engraved cylinder and which extends over the length of the ink chamber profile, the ink chamber profile being sealed at its extremities by flexible seals, said ink chamber profile, end seals, doctor blades and engraved cylinder demarcating an ink cavity, characterized in that there is further provided a shuttle member within the ink cavity, said shuttle member being movable substantially along the entire length of the ink chamber profile in order to aid purging of residual ink from said ink cavity, said shuttle member further being provided with associated drive means to induce

Abstract: A method for separating a hydrocarbon content from a hydrocarbon contaminated matrix is disclosed. The method comprises controlling a water content of a feed material comprising the hydrocarbon contaminated matrix; continuously conveying the feed material into a treatment cavity (3), exposing the feed material in a treatment area (8) of the treatment cavity to microwave radiation arranged to cause rapid heating of at least a portion of the water content to form steam, wherein the rapid steam formation results in thermal desorption of at least a portion of the hydrocarbon content from the matrix; and continuously removing the treated matrix from the treatment cavity.

Abstract: Compounds of Formula (I) wherein R1, R2, R3, R4, R5, R6, and R7 are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.

Abstract: An aqueous dispersion comprises: (A) water; (B) a polymeric material of a type which includes: (a) phenyl moieties; (b) carbonyl and/or sulphone moieties; and (c) ether and/or thioether moieties; (C) a surface active agent which includes a carbonyl or sulphone moiety and a hydrophilic group. Preferred embodiments relate to polyketones in combination with surfactants which are alkyl sulphosuccinates.

Abstract: The present invention provides reagents, compounds, compositions, and methods relating to novel interactions of the extracellular domain of LRP5, HBM (a variant of LRP5), and/or LRP6 with Dkk, including Dkk-1. The various nucleic acids, polypeptides, antibodies, assay methods, diagnostic methods, and methods of treatment of the present invention are related to and impact on Dkk, LRP5, LRP6, HBM, and Wnt signaling. Dkk, LRP5, LRP6, HBM, and Wnt are implicated in bone and lipid cellular signaling. Thus, the present invention provides reagents and methods for modulating lipid levels and/or bone mass and is useful in the treatment and diagnosis of abnormal lipid levels and bone mass disorders, such as osteoporosis.

Abstract: A low cost flexible substrate is described which comprises a thin metal foil and a layer of solder mask. The metal foil layer is patterned to create tracks and lands for solder bonding and/or wirebonding and the layer of solder mask is patterned to create openings for solder bonding, wirebonding and/or for mounting the die. The substrate may be used as a package substrate to create a packaged die or may be used as a replacement for more expensive flexible printed circuit boards.

Abstract: Metallised through silicon vias located in the scribe lanes between die are used to create an electrical connection between the front-side and the rear-side of a silicon die. One of the metallisation layers on the front-side of the die comprises portions which extend into the scribe lanes to form capture pads for the through silicon vias. The rear-side of the wafer is metallised and this metallisation may, in some embodiments, be patterned to form tracks or components. The silicon die may be used to create improved package on package devices. In other examples, other substrate materials may be used.